MTD
Mettler-Toledo International, I
NYSEUSDEQUITY
Healthcare
DELAYED
Last price
1,398.94
▲ 5.71 (0.41%)
MARKET · —
Price
Open
1,393.23
Prev close
1,393.23
Day high
1,404.52
Day low
1,377.43
Volume
318.06K
Market cap
$27.96B
P/E (TTM)
31.45
52W range
1,023.05 – 1,525.17
Trailing performance
Returnvs SPY
1W
-1.68%
-0.3%
1M
+4.76%
+1.0%
3M
+27.95%
+24.9%
6M
+1.28%
-9.8%
YTD
+0.08%
-12.2%
1Y
+5.95%
-14.0%
3Y
+16.44%
-57.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$27.96B
Enterprise value$30.04B
Revenue (TTM)$4.13B
Gross profit$2.49B
EBITDA$1.28B
Net income$905.61M
EPS (TTM)$44.37
Free cash flow$693.59M
Total cash$51.38M
Total debt$2.14B
Book value / share$0.64
Shares outstanding20.04M
Float19.93M
Short % of float4.52%
Dividend yield—
Beta (5Y)1.22
Valuation & profitability ratios
Trailing P/E31.45
Forward P/E26.99
PEG ratio2.91
Price / sales—
Price / book2,180.08
EV / revenue7.27
EV / EBITDA23.55
Gross margin60.26%
Operating margin31.20%
Profit margin21.91%
Return on equity—
Return on assets21.10%
Debt / equity16,668.45
Current ratio1.12
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $4.03B | $3.87B | $3.79B | $3.92B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $869.19M | $863.14M | $788.78M | $872.50M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $869.19M | $863.14M | $788.78M | $872.50M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 10.81 | 11.46 | +6.0% |
| Mar 2026 | 8.71 | 8.91 | +2.3% |
| Dec 2025 | 12.81 | 13.36 | +4.3% |
| Sep 2025 | 10.66 | 11.15 | +4.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 12.11 | 11 | $1.07B | +4.0% |
| Next quarter | 14.89 | 11 | $1.18B | +4.6% |
| Current year | 47.34 | 12 | $4.23B | +5.1% |
| Next year | 51.69 | 12 | $4.44B | +4.8% |
Analyst targets & ownership
Mean target$1,468.91
High target$1,600.00
Low target$1,200.00
Implied upside5.00%
Analyst count11
ConsensusNONE
Strong buy / Buy1 / 4
Hold6
Sell / Strong sell0 / 1
Held by insiders0.44%
Held by institutions105.56%
Institutions holding1.23K
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+1.46K
Net buying
Buy transactions
10
4.77K shares
Sell transactions
4
3.31K shares
Net transactions
+14
Buys less sells
Sell : buy shares
0.7 : 1
Mixed
Insider-held shares
87.76K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 5, 26 | SALICE THOMAS P Director |
CONVERSION | 417 | $165.94K | Direct |
| Aug 5, 26 | SALICE THOMAS P Director |
SELL | 417 | $600.65K | Direct |
| Aug 3, 26 | KELLER GERRY Officer |
SELL | 240 | $342.51K | Direct |
| Aug 3, 26 | VADALA SHAWN P. Chief Financial Officer |
SELL | 2.24K | $3.21M | Direct |
| Aug 3, 26 | KELLER GERRY Officer |
CONVERSION | 240 | $172.99K | Direct |
| Aug 3, 26 | VADALA SHAWN P. Chief Financial Officer |
CONVERSION | 2.24K | $1.33M | Direct |
| Aug 3, 26 | SALICE THOMAS P Director |
CONVERSION | 415 | $165.15K | Direct |
| Aug 3, 26 | SALICE THOMAS P Director |
SELL | 415 | $599.52K | Direct |
| May 12, 26 | KELLER GERRY Officer |
STOCK | 100 | $0 | Direct |
| May 12, 26 | WONG ANN PING RICHARD Officer |
STOCK | 103 | $0 | Direct |
| May 12, 26 | GRAHAM-BRYCE SUSAN Officer |
STOCK | 71 | $0 | Direct |
| May 12, 26 | WITTORF OLIVER Officer |
STOCK | 87 | $0 | Direct |
| May 12, 26 | VADALA SHAWN P. Chief Financial Officer |
STOCK | 291 | $0 | Direct |
| May 12, 26 | KALTENBACH PATRICK Chief Executive Officer |
STOCK | 810 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
DIGGELMANN ROLAND D |
Director | 732 | Stock Award(Grant) |
FRANCIS RICHARD D |
Director | 624 | Stock Award(Grant) |
GRAHAM-BRYCE SUSAN |
Officer | 517 | Stock Award(Grant) |
KALTENBACH PATRICK |
Chief Executive Officer | 4.48K | Stock Award(Grant) |
KELLY MICHAEL A |
Director | 1.81K | Stock Award(Grant) |
MAGLOTH CHRISTIAN |
Officer | 734 | Sale |
SALICE THOMAS P |
Director | 52.78K | Conversion of Exercise of derivative security |
VADALA SHAWN P. |
Chief Financial Officer | 5.58K | Sale |
WITTORF OLIVER |
Officer | 495 | Stock Award(Grant) |
WONG ANN PING RICHARD |
Officer | 645 | Stock Award(Grant) |
Moving averages & technicals
SMA 10
1,418.37
-1.37% from price
SMA 20
1,412.39
-1.21% from price
SMA 50
1,315.89
+6.03% from price
SMA 100
1,263.88
+10.69% from price
SMA 200
1,321.53
+5.58% from price
EMA 12
1,408.84
-0.70% from price
EMA 26
1,383.71
+1.10% from price
EMA 50
1,339.01
+4.48% from price
RSI (14)
53.6
Neutral
MACD (12,26,9)
25.13
Hist -9.74
ATR (14)
34.88
2.50% of price
Realised vol 30D
24.1%
Annualised
Bollinger upper
1,463.40
20, 2σ
Bollinger lower
1,361.38
20, 2σ
50 / 200 cross
Death
1,315.89 vs 1,321.53
Trend bias
Above 200
+5.58%
Risk profile
Beta vs SPY
0.83
Less volatile than market
Correlation to SPY
0.33
Loosely linked
Realised vol 30D
24.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-31.9%
Peak to trough
Max drawdown 5Y
-43.5%
Peak to trough
ATR 14
34.88
2.50% of price
Beta (reported)
1.22
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.80
Call-heavy session
Put / call open interest
0.86
Positioning, not flow
Max pain
1,430.00
+2.5% from spot
ATM implied vol
31.0%
Nearest strike to spot
Skew (10% OTM)
-4.0%
Calls bid over puts
Call volume
10
Contracts, this expiry
Put volume
8
Contracts, this expiry
Heaviest call OI
1,540.00
7 contracts
Heaviest put OI
1,330.00
10 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Mettler-Toledo (MTD) Upgraded to Buy: Here's Why
Zacks · 19h ago
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
StockStory · 2d ago
Beat the Market the Zacks Way: Bank of America, Marex, Mettler-Toledo International in Focus
Zacks · 5d ago
What Investors Should Know About a Mettler-Toledo Director's Two Transactions This Past Week
Motley Fool · 11d ago
What Investors Should Know as Mettler-Toledo Insiders Sell Shares After a Strong Quarter
Motley Fool · 11d ago
A Mettler-Toledo Director Sold $600,000 in Stock. Here's What Investors Should Know
Motley Fool · 12d ago
Mettler-Toledo's CFO Cashed In Options After a Strong Quarter. Here's What to Know
Motley Fool · 12d ago
2 Mid-Cap Stocks to Target This Week and 1 Facing Headwinds
StockStory · 12d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.